Intravenous low-dose iron administration in hemodialysis patients treated with erythropoietin: 1-year follow-up study.
Kurihara
I
I
Soma
J
J
Nakayama
K
K
Sato
H
H
Saito
T
T
D015415:Biomarkers / Q000097:blood; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D005293:Ferritins / Q000097:blood; D005500:Follow-Up Studies; D006400:Hematocrit; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis; D013997:Time Factors
D015415:Biomarkers; D005290:Ferric Compounds; D011994:Recombinant Proteins; D004921:Erythropoietin; C000499:ferric oxide; D005293:Ferritins; D007501:Iron